Drawing for HEARO

USPTO serial 88876444

HEARO

Reviewed by CopyMark Law Group

Reg. 6414311Status 700Renewal
Filing date
Status date
Registration date
Jul 13, 2021
Examiner
EUBANK, REBECCA A
Law office
PUBLICATION AND ISSUE SECTION

What this means

This registration is in, or will soon enter, a USPTO maintenance window. Missing a Section 8 or Section 9 filing can cancel the registration.

Status 700: Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

Need help with HEARO?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Get help with this Renewal, set up monitoring, or talk with CopyMark.
Get Attorney Assistance for just $548*

Plus Government fees of $650

Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

James Barta

James Barta Barta Jones PLLC3308 Preston RoadSte 350-161Plano, TX 75093

Goods and services

ClassDescriptionStatusFirst use
009Downloadable mobile applications that use artificial intelligence to automate the monitoring of individuals with intellectual and developmental disabilities at home in the field of healthcare; downloadable mobile application in the field of healthcare for automated monitoring of patient medication, health emergencies and reminders, environmental data, home security and monitoring for use by families and provider agencies supporting those with intellectual and developmental disabilities; Downloadable computer software for automated monitoring of patient medication, health emergencies and reminders, environmental data, home security and monitoring for use by families and provider agencies supporting those with intellectual and developmental disabilities; Downloadable computer software that simplifies voice and video communications between provider agencies and the individuals with intellectual and developmental disabilities that they serve in the field of healthcare. None of the foregoing goods are for the medical diagnosis, management, and monitoring of certain conditions, namely in the nature of heart and cardio-vascular related conditions, lung related conditions, mental health conditions, medical conditions relating to speech and voice, and COVID 19 through products that monitor the human voice, speech, and breathingACTIVEJan 1, 2019
042Research and development of assistive technology in the field of healthcare for use by organizations supporting those with intellectual and developmental disabilities; development of computer software designed for the automated monitoring of patient medication, health emergencies and reminders, environmental data, home security and monitoring for use by families and provider agencies supporting those with intellectual and developmental disabilities; Technical support services, namely, remote troubleshooting in the nature of diagnosing computer hardware and software problems administration and management of in-house and hosted datacenter devices, databases and software applications; development of computer platforms; Platform as a service (PAAS) featuring computer software platforms for increasing the independence of seniors or persons with developmental disabilities by providing support remotely in real time using technology, video and voice communication between parties, activity and medication reminders, and information gathered through a variety of devices to provide both active and passive notifications to ensure the short-term and long-term safety of those being supported; Providing online, non-downloadable computer software for automated monitoring of patient medication, health emergencies and reminders, environmental data, home security and monitoring for use by families and provider agencies supporting those with intellectual and developmental disabilities; Providing online, non-downloadable computer software that simplifies voice and video communications between provider agencies and individuals with intellectual and developmental disabilities that they serve in the field of healthcare. None of the foregoing services are for the medical diagnosis, management, and monitoring of certain conditions, namely in the nature of heart and cardio-vascular related conditions, lung related conditions, mental health conditions, medical conditions relating to speech and voice, and COVID 19 through products that monitor the human voice, speech, and breathingACTIVEJan 1, 2019

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Jul 13, 2026REM1COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED—
May 22, 2025TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
May 22, 2025ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
May 22, 2025REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Jul 13, 2021R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Apr 27, 2021NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Apr 27, 2021PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Apr 7, 2021NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Mar 24, 2021CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Mar 18, 2021TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Mar 17, 2021CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Mar 17, 2021ERSITEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED—
Jan 28, 2021GNS3NOTIFICATION OF LETTER OF SUSPENSION E-MAILED—
Jan 28, 2021GNSLLETTER OF SUSPENSION E-MAILED—
Jan 28, 2021CNSLSUSPENSION LETTER WRITTEN—
Jan 16, 2021TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Jan 15, 2021CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Jan 15, 2021TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jul 15, 2020GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jul 15, 2020GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jul 15, 2020CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jul 9, 2020DOCKASSIGNED TO EXAMINER—
Apr 27, 2020NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Apr 21, 2020NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance